Literature DB >> 25907836

The Potential Application of Mitochondrial Medicine in Toxicologic Poisoning.

David H Jang1, Joshua W Lampe, Lance B Becker.   

Abstract

The advancement of biomolecular techniques has continued to advance in the area of mitochondrial medicine. This has allowed clinicians and researchers to more effectively study the bioenergetics of the mitochondria in various disease states. One potential technique in mitochondrial medicine is the generation of cytoplasmic hybrids. A cytoplasmic hybrid or cybrid are created by introducing mitochondrial DNA (mtDNA) of interest into cells depleted of mtDNA. A cybrid is therefore a hybrid cell that mixes the nuclear genome from one cell with the mitochondrial genes from another cell. Cybrids are currently utilized in mitochondrial research to demonstrate mitochondrial involvement in a wide range of diseases that include diabetes, Parkinson's disease and inherited diseases. At this time the use of cybrids to study toxicologic poisoning is limited and offers a potential avenue of research in this area.

Entities:  

Mesh:

Year:  2015        PMID: 25907836      PMCID: PMC4469712          DOI: 10.1007/s13181-015-0478-8

Source DB:  PubMed          Journal:  J Med Toxicol        ISSN: 1556-9039


  27 in total

Review 1.  Diagnosis and management of MELAS.

Authors:  Madhav Thambisetty; Nancy J Newman
Journal:  Expert Rev Mol Diagn       Date:  2004-09       Impact factor: 5.225

Review 2.  Mitochondrial function, energy expenditure, aging and insulin resistance.

Authors:  P Ritz; G Berrut
Journal:  Diabetes Metab       Date:  2005-12       Impact factor: 6.041

3.  Clinical, genetic, and biochemical characterization of a Leber hereditary optic neuropathy family containing both the 11778 and 14484 primary mutations.

Authors:  M D Brown; J C Allen; G P Van Stavern; N J Newman; D C Wallace
Journal:  Am J Med Genet       Date:  2001-12-15

4.  Clustering of Caucasian Leber hereditary optic neuropathy patients containing the 11778 or 14484 mutations on an mtDNA lineage.

Authors:  M D Brown; F Sun; D C Wallace
Journal:  Am J Hum Genet       Date:  1997-02       Impact factor: 11.025

5.  Use of transmitochondrial cybrids to assign a complex I defect to the mitochondrial DNA-encoded NADH dehydrogenase subunit 6 gene mutation at nucleotide pair 14459 that causes Leber hereditary optic neuropathy and dystonia.

Authors:  A S Jun; I A Trounce; M D Brown; J M Shoffner; D C Wallace
Journal:  Mol Cell Biol       Date:  1996-03       Impact factor: 4.272

6.  Ethidium bromide-induced loss of mitochondrial DNA from primary chicken embryo fibroblasts.

Authors:  P Desjardins; E Frost; R Morais
Journal:  Mol Cell Biol       Date:  1985-05       Impact factor: 4.272

Review 7.  Pesticides and human diabetes: a link worth exploring?

Authors:  K Swaminathan
Journal:  Diabet Med       Date:  2013-11       Impact factor: 4.359

8.  On auxotrophy for pyrimidines of respiration-deficient chick embryo cells.

Authors:  M Grégoire; R Morais; M A Quilliam; D Gravel
Journal:  Eur J Biochem       Date:  1984-07-02

Review 9.  Cytoplasmic hybrid (cybrid) cell lines as a practical model for mitochondriopathies.

Authors:  Heather M Wilkins; Steven M Carl; Russell H Swerdlow
Journal:  Redox Biol       Date:  2014-04-01       Impact factor: 11.799

10.  Cytoplasmic transfer of chloramphenicol resistance in human tissue culture cells.

Authors:  D C Wallace; C L Bunn; J M Eisenstadt
Journal:  J Cell Biol       Date:  1975-10       Impact factor: 10.539

View more
  2 in total

1.  A preliminary study in the alterations of mitochondrial respiration in patients with carbon monoxide poisoning measured in blood cells.

Authors:  David H Jang; Matthew Kelly; Kevin Hardy; David S Lambert; Frances S Shofer; David M Eckmann
Journal:  Clin Toxicol (Phila)       Date:  2017-02-16       Impact factor: 4.467

2.  Alterations in Mitochondrial Function in Blood Cells Obtained From Patients With Sepsis Presenting to an Emergency Department.

Authors:  David H Jang; Clinton J Orloski; Shawn Owiredu; Frances S Shofer; John C Greenwood; David M Eckmann
Journal:  Shock       Date:  2019-05       Impact factor: 3.454

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.